Dr. Aude Segaliny
Dr. Segaliny is a founding scientist of Amberstone Biosciences. She currently serves as the Head of Assay Biology and Scientific Liaison, where she has spearheaded efforts in developing platform biology to enable the discovery of transformative immunotherapeutics. She has over 10 years of experience in cell-based assays, cancer biology and immunology.
Monday 6th May
Higher order structure and molecular mechanism of action analysis for accelerated drug design